TAK
Takeda Pharmaceutical Company Limited
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · JP
$18.45
−1.39%Margins
Gross margin
59.0%
EBITDA margin
27.2%
EBIT margin
11.0%
Net margin
3.9%
FCF margin
12.0%
2.4%
Return on equity
1.2%
Return on assets
4.1%
Return on invested capital
0.30x
Asset turnover
$6.1B
Cash from operations
$1.06
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026